v3.26.1
Share-Based Compensation
 6 Months Ended
Jan. 31, 2026
Share-Based Compensation [Abstract]  
SHARE-BASED COMPENSATION

NOTE 14 — SHARE-BASED COMPENSATION

 

On December 17, 2025, the Company granted 2,000,000 stock options to employees. As the awards were fully vested on the grant date, the Company recognized the entire grant-date fair value of the options as share-based compensation expense on December 17, 2025. The grant-date fair value of options granted during the six months ended January 31, 2026 was $1,913,692

 

The grant-date fair value of the stock options was estimated using the Black-Scholes option pricing model. The determination of the fair value of share-based awards on the grant date using an option pricing model is affected by the Company’s stock price, as well as assumptions regarding a number of complex and subjective variables. These variables include the expected term of the options, expected stock price volatility, risk-free interest rate, and expected dividend yield.

 

The following table presents the allocation of share-based compensation expense by functional expense category for the periods presented:

 

   For the Six Months Ended January 31, 
   2026   2025 
   (Unaudited)   (Unaudited) 
Cost of revenue  $223,942   $
       —
 
General & administrative expenses   10,181    
—
 
Research & development expenses   559,855    
—
 
Sales and marketing expenses   1,119,714    
—
 
Total share-based compensation expenses  $1,913,692   $
—
 

 

As of January 31, 2026, there was no unrecognized compensation cost related to unvested stock options.

 

   For the Six Months Ended
January 31,		 
   2026 
Expected volatility   60.67%
Expected term (years)   5 
Risk-free interest rate   3.70%
Expected dividend yield   
—
%

 

The following table summarizes stock option activity for the six months ended January 31, 2026:

 

   Number of Options   Weighted-average Exercise Price 
Outstanding at July 31, 2025   
—
   $
    —
 
Granted   2,000,000    1.75 
Exercised   
—
    
—
 
Forfeited   
—
    
—
 
Outstanding at January 31, 2026   2,000,000   $1.75 

 

All outstanding options were vested and exercisable as of January 31, 2026. No options were exercised during the six months ended January 31, 2026.